
Universal Health Services (UHS) Stock
Major US operator of hospitals and mental health centers. Here's the price, business snapshot, and what's worth knowing about Universal Health Services in November 2026.
Universal Health Services, Inc. (UHS) operates acute-care hospitals, behavioural health centres and outpatient facilities, primarily in the United States. With a market cap around $13.16bn, the company earns revenue from patient services, insurance reimbursements and government programmes. Investors often view UHS as part of the defensive healthcare sector: demand for hospital and mental-health services tends to persist through economic cycles, though profitability depends on reimbursement rates, occupancy and cost control. Key considerations include regulatory and litigation risk, labour and supply cost pressures, and the capital intensity of running hospital networks. Recent performance can be influenced by payer mix, contract negotiations and efficiency initiatives. This summary is general educational information, not personalised investment advice. Values can rise and fall and past performance is not a guide to the future; suitability depends on your circumstances and risk tolerance.
Six-Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend holding Universal Health Services' stock with a target price of $199.79, indicating slight growth potential.
Financial Health
Universal Health Services is performing well financially with strong revenue and cash flow generation.
Dividend
Universal Health Services' dividend yield of 0.31% is low, which may not attract income-focused investors. If you invested $1000, you would be paid $6 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Steady Demand Drivers
Ageing populations and ongoing need for acute and mental-health services support baseline demand, though revenue can be affected by payer mix and reimbursement changes.
Geographic Footprint
Primarily US-focused with varied sites and services; geographic and service diversification can help resilience, but regulatory differences add complexity.
Cost & Efficiency Focus
Margins often hinge on labour, supply costs and operational efficiency—improvements can boost results, yet performance may vary and carry execution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.